Fusion Pharmaceuticals
single dose eradicated tumors in mice | Fusion Pharmaceuticals
Company
Deck Type
IPO
Sector
Industry
Deck date
June 2020
Slide
19 of 49
Related slides by other companies
Apexigen
Investor Presentation
September 2022
single dose of turns cold tumor hot data presented at some | Apexigen
Enochian Biosciences
Investor Presentation
January 2024
treated mice showed no signs of metastatic disease | Enochian Biosciences
Chimerix
Investor Presentation
August 2023
dose pediatric and adult tumors dose trials enrolling in parallel for adult and pediatric tumors response reported by investigator from early cohort without mutation once weekly dose is expected to intensify to three consecutive days per week national institutes of health pacific | Chimerix
Chimerix
Investor Presentation
May 2023
dose pediatric and adult tumors | Chimerix
Other recent decks by Fusion Pharmaceuticals
See all presentations (4 decks)
Investor Presentation
January 2024
Investor Presentation
November 2023
Investor Presentation
August 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights